The Impact of Genetic Variation in CYP2D6 on the Pharmacokinetics and Pharmacodynamics of Methamphetamine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01529892
Recruitment Status : Withdrawn
First Posted : February 9, 2012
Last Update Posted : May 31, 2013
Children's Mercy Hospital Kansas City
Information provided by (Responsible Party):
John Mendelson, MD, California Pacific Medical Center Research Institute

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given